| Participant characteristics | ||
---|---|---|---|
Core model | |||
 | Pregnant (n = 4379, 12.0%) | Non-pregnant (n = 32,119, 88.0%) | Risk estimate (95% CI) |
 Mean age (years), SD | 26.7 ± 6.1 | 29.2 ± 8.7 | MD 2.43 (2.23–2.64) |
 Antiviral treatment | 2073 (55.4%) | 8452 (28.7%) | OR 3.09 (2.88–3.31) |
 Vaccinateda | 367 (12.1%) | 2221 (7.8%) | OR 1.62 (1.44–1.82) |
 Diabetes mellitus | 150 (3.9%) | 1094 (3.8%) | OR 1.03 (0.86–1.22) |
 Cardio-respiratory | 287 (7.7%) | 2186 (7.5%) | OR 1.03 (0.91–1.18) |
 Immunosuppressionc | 74 (2.0%) | 814 (2.8%) | OR 0.69 (0.54–0.87) |
Secondary model | |||
 Obesity | 107 (4.3%) | 963 (4.7%) | OR 0.92 (0.75–1.13) |
 Smoking | 77 (4.6%) | 762 (3.3%) | OR 1.43 (1.12–1.81) |
 Chronic respiratoryb | 251 (6.9%) | 1907 (6.6%) | OR 1.05 (0.91–1.20) |